Search results
Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study
Zacks via Yahoo Finance· 1 month agoRoche Holding AG RHHBY announced that the late-stage study evaluating its marketed drug, Columvi...
Lifesaving cancer treatment out of reach for rural people
NBC News via Yahoo News· 2 years agoSuzanne BeHanna initially turned down an experimental but potentially lifesaving cancer treatment....
Roche (RHHBY) Blood Cancer Drug Columvi Wins EC Approval
Zacks via Yahoo Finance· 11 months agoRoche RHHBY obtained conditional marketing authorization from the European Commission (EC) for its...
Oncternal (ONCT) Down on Restructuring Plan to Extend Runway
Zacks via Yahoo Finance· 1 year agoShares of clinical-stage biopharmaceutical company Oncternal Therapeutics, Inc. ONCT plunged 59.3%...
Biotech Stock Roundup: EPZM Soars on IPSEY Offer, KZR Up on Study Data & More
Zacks via Yahoo Finance· 2 years agoThe biotech sector has been in the spotlight in the past week with important pipeline and regulatory...
Chronic Lymphocytic Leukemia: Slow-Appearing Symptoms
Verywell Health via Yahoo News· 10 months agoNew therapies are transforming treatment Halfpoint Images / Getty Images Medically reviewed by...
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Zacks via Yahoo Finance· 1 month agoThis week, J&J JNJ began the first-quarter 2024 earnings season for the pharma space with mixed...
Mark Hoppus Says He’s ‘Open to Whatever’ for Blink-182 After Rekindling Friendship with Tom DeLonge
Billboard via Yahoo News· 2 years agoMark Hoppus says he’s open to all possibilities after his battle with stage 4 diffuse large B-cell...
Pharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New Indication
Zacks via Yahoo Finance· 2 years agoThis week, Merck MRK offered to buy Imago Biosciences IMGO, which is developing drugs to treat bone...
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III
Zacks via Yahoo Finance· 10 months agoThis week, AstraZeneca AZN, Sanofi SNY and AbbVie ABBV and Roche announced second-quarter earnings....